Sodium-Glucose Co-Transporter 2 Inhibitors Use Improves the Satisfaction With Anti-diabetic Agent Treatment: A Questionnaire-based Propensity Score-matched Study

Background: Specific safety issues with sodium-glucose co-transporter-2 (SGLT2) inhibitors such as infection, fractures, worsening of renal function and euglycemic ketoacidosis have been raised. Concerns about adverse events might limit the use of this drug class. The satisfaction with SGLT2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Fang-Hong, Yue, Jiang, Jiang, Yi-Hong, Yang, Ming-Lan, Gu, Zhi-Chun, Ma, Jing, Li, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844021/
https://www.ncbi.nlm.nih.gov/pubmed/35177981
http://dx.doi.org/10.3389/fphar.2021.787704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844021/
https://www.ncbi.nlm.nih.gov/pubmed/35177981
http://dx.doi.org/10.3389/fphar.2021.787704

Ejemplares similares